Cargando…

Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy

Persistent immune activation plays a central role in driving Human Immunodeficiency Virus (HIV) disease progression. Whether CD4+CD25+ regulatory T cells (Tregs) are harmful by suppressing HIV-specific immune responses and/or beneficial through a decrease in immune activation remains debatable. We a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Laurence, Piketty, Christophe, Assoumou, Lambert, Didier, Céline, Caccavelli, Laure, Donkova-Petrini, Vladimira, Levy, Yves, Girard, Pierre-Marie, Burgard, Marianne, Viard, Jean-Paul, Rouzioux, Christine, Costagliola, Dominique
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908121/ https://www.ncbi.nlm.nih.gov/pubmed/20657770 http://dx.doi.org/10.1371/journal.pone.0011659

Ejemplares similares

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
por: Sáez-Cirión, Asier, et al.
Publicado: (2013)

Persistence of anal squamous intraepithelial lesions and anal HPV infection in HIV-infected patientsdespite immune restoration under cART
por: Piketty, C, et al.
Publicado: (2010)

Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study
por: Warszawski, Josiane, et al.
Publicado: (2016)

Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Predictors of SIV recrudescence following antiretroviral treatment interruption
por: Pinkevych, Mykola, et al.
Publicado: (2019)

Pro-viral DNA and antiretroviral treatment simplification
por: Zucman, D, et al.
Publicado: (2010)

Factors associated with antiretroviral treatment interruption in human immunodeficiency virus (HIV)-1-infected children attending the Jos University Teaching Hospital, Jos, Nigeria
por: Ebonyi, Augustine O., et al.
Publicado: (2015)

Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model
por: Goswami, Ria, et al.
Publicado: (2019)

Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption
por: Ziani, Widade, et al.
Publicado: (2021)

Immunological predictors of CD4(+ )T cell decline in antiretroviral treatment interruptions
por: Seoane, Elena, et al.
Publicado: (2008)

Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa
por: Mills, Edward J., et al.
Publicado: (2013)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
por: Garner, Samual A, et al.
Publicado: (2017)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
por: Bonney, Evelyn Y., et al.
Publicado: (2021)

Association of Residual Plasma Viremia and Intima-Media Thickness in Antiretroviral-Treated Patients with Controlled Human Immunodeficiency Virus Infection
por: Boyd, Anders, et al.
Publicado: (2014)

Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
por: Costagliola, Giorgio, et al.
Publicado: (2021)

Primary Immunodeficiencies: Pathogenetic Advances, Diagnostic and Management Challenges
por: Costagliola, Giorgio, et al.
Publicado: (2023)

The Th17/Treg Ratio, IL-1RA and sCD14 Levels in Primary HIV Infection Predict the T-cell Activation Set Point in the Absence of Systemic Microbial Translocation
por: Chevalier, Mathieu F., et al.
Publicado: (2013)

Maternal CD4+ Cell Count Decline after Interruption of Antiretroviral Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV
por: Ekouevi, Didier, et al.
Publicado: (2012)

Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity — The ANRS-EP38-IMMIP Study
por: Le Chenadec, Jérôme, et al.
Publicado: (2015)

Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?
por: Veenstra, Nina, et al.
Publicado: (2010)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
por: Harrison, Linda, et al.
Publicado: (2012)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

Advances and challenges in antiretroviral therapy for acquired immunodeficiency syndrome
por: Bai, Ruo-Jing, et al.
Publicado: (2020)

Combination Antiretroviral Therapy and Immunophenotype of Feline Immunodeficiency Virus
por: Kim, Jeffrey, et al.
Publicado: (2023)

French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults
por: Hoen, Bruno, et al.
Publicado: (2014)

Antiretroviral activity of Pterois volitans (red lionfish) venom in the early development of human immunodeficiency virus/acquired immunodeficiency syndrome antiretroviral alternative source
por: Sommeng, Andy Noorsaman, et al.
Publicado: (2019)

18-Month Effectiveness of Short-Course Antiretroviral Regimens Combined with Alternatives to Breastfeeding to Prevent HIV Mother-to-Child Transmission
por: Leroy, Valériane, et al.
Publicado: (2008)

Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users
por: Slama, Laurence, et al.
Publicado: (2023)

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment
por: Pantazis, Nikos, et al.
Publicado: (2016)

Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical Implications
por: Costagliola, Giorgio, et al.
Publicado: (2021)

Adherence to antiretrovirals in people coinfected with the human immunodeficiency virus and tuberculosis
por: Lemos, Larissa de Araújo, et al.
Publicado: (2016)

Conjunctival Flora of Human Immunodeficiency Virus Patients on Antiretroviral Treatment
por: Giles, Kagmeni, et al.
Publicado: (2017)

Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy
por: Bosamiya, Sanjay S., et al.
Publicado: (2014)

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
por: De Castro, Nathalie, et al.
Publicado: (2022)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
por: Gisslén, Magnus, et al.
Publicado: (2005)

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
por: Park, You Jeong, et al.
Publicado: (2017)

Predictors of antiretroviral therapy interruptions and factors influencing return to care at the Nkolndongo Health District, Cameroon
por: Nsoh, Marius, et al.
Publicado: (2021)

Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
por: Sudharshan, Sridharan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p083kft77mj3304snd971neh57